Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Seoyoung Catherine Kim, Sc.D., M.D.


This page shows the publications co-authored by Seoyoung Kim and Candace Feldman.
Connection Strength

  1. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. Arthritis Rheumatol. 2017 02; 69(2):387-397.
    View in: PubMed
    Score: 0.715
  2. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs. Lupus. 2017 Jun; 26(7):682-689.
    View in: PubMed
    Score: 0.702
  3. Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases. PLoS One. 2015; 10(2):e0117620.
    View in: PubMed
    Score: 0.624
  4. Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake? Expert Rev Vaccines. 2014 Aug; 13(8):931-4.
    View in: PubMed
    Score: 0.596
  5. Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study. BMJ Open. 2019 06 19; 9(6):e027495.
    View in: PubMed
    Score: 0.211
  6. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015 Jun; 67(6):1577-85.
    View in: PubMed
    Score: 0.159
  7. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications. Rheumatology (Oxford). 2021 08 02; 60(8):3789-3798.
    View in: PubMed
    Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.